Action is the latest following Baldwin’s investigation into the extremely high prices these companies charge for inhalers ...

Americans with asthma and 16 million Americans with COPD need inhalers to breathe. Vermont Business Magazine Sen. Bernie Sanders (I-Vermont), Chairman of the Senate Com ...

GSK PLC GSK shares inched down 0.34% to £13.30 Friday, on what proved to be an all-around grim trading session for the stock ...

Pascal Soriot is stuck in a Chinese limbo. In recent months, the CEO of $205 billion drug giant AstraZeneca has seen his ...

The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients with circulating tumor DNA (ctDNA), failed to accrue enough patients ...

The industry’s most influential marketers include brand-side executives from Philips, GSK, Disney and Samsung, as well as ...

PCM receives funding from the Francis Crick Institute (CC2223); University College London Hospitals National Institute for Health and Care Research Biomedical Research Centre; and has received funding ...

GSK has made the decision to withdraw Jesduvroq (daprodustat), a hypoxia-inducible factor prolyl hydroxylase inhibitor, from the US market.

With that in mind, GSK is partnering with developer Reef and investor UBS Asset Management to build a 1.4M SF, £900M life ...

The data include an interim look at the dose-escalation portion of a phase 2 trial assessing the adenosine A2A receptor ...

Updated results from the DREAMM-7 trial support the use of belantamab mafodotin plus bortezomib and dexamethasone “as a potential new standard of care,” according to Vania Hungria, MD, PhD.

November 2024 has seen a variety of biotech deals take place to advance therapies across different stages in development.